Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2024

Content (21 Articles)

Lifestyle interventions with dietary strategies after breast cancer diagnosis: a systematic review

Acadia W. Buro, Tam Nguyen, Michael Abaskaron, Mary Katherine Haver, Tiffany L. Carson

A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer

Sanjay Kumar Yadav, S. Bharath, Dhananjaya Sharma, Anurag Srivastava, Chandan Kumar Jha, Gaurav Agarwal, Sarada Khadka, Manju Singh, Saket Shekhar, Amit Goyal

An exploratory clinical trial of preoperative non-invasive localization before breast-conserving surgery using augmented reality technology

Minah Lee, Joohyun Woo, Se Hyun Peak, Hyun Goo Kim, Woo Sung Lim, Jin Chung, Jee Eun Lee, Jeoung Hyun Kim, Sanghui Park, Ji Min Kim, Jun Woo Lee

Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?

Chen-feng Tan, Jun Wang, Xiao-rong Zhong, Ze-lei Dai, Zhong-zheng Xiang, Yuan-yuan Zeng, Xiao-yuan Wei, Ning-yue Xu, Lei Liu

Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study

Carl Blomqvist, Leena Vehmanen, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Johanna Ruohola, Heidi Penttinen, Harri Sievänen, Riku Nikander, Meri Utriainen, Tiina Saarto

BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization

Rinat Yerushalmi, Adi Pomerantz, Ron Lewin, Shani Paluch-Shimon, Lior Soussan-Gutman, Frederick L. Baehner, Hillary Voet, Avital Bareket-Samish, Inbal Kedar, Yael Goldberg, Tamar Peretz-Yablonski, Luna Kadouri

Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses’ Health Studies

Renée T. Fortner, Kristen D. Brantley, Shelley S. Tworoger, Rulla M. Tamimi, Bernard Rosner, Michelle D. Holmes, Walter C. Willett, A. Heather Eliassen

Multi-omics portrait of ductal carcinoma in situ in young women

  • Original Laboratory Investigation

Ruoxi Hong, Boyang Cao, Dongshao Chen, Wei Wu, Tian Luo, Dian Lv, Weimin Zhang, Shusen Wang, Kang Shao

Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival—a propensity score cohort study

Sergi Fernandez-Gonzalez, Catalina Falo, Maria J. Pla, Miriam Campos, Carlos Ortega-Exposito, Raul Ortega, Maria Vicente, Ana Petit, Jan Bosch-Schips, Maria Teresa Bajen, Gabriel Reyes, Evelyn Martínez, Javier González-Viguera, Judith Peñafiel, Agostina Stradella, Sonia Pernas, Jordi Ponce, Amparo Garcia-Tejedor

Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value

Inas Alhudiri, Christopher Nolan, Ian Ellis, Adam Elzagheid, Andrew Green, Caroline Chapman

Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay

Yinxi Wang, Wenwen Sun, Emelie Karlsson, Sandy Kang Lövgren, Balázs Ács, Mattias Rantalainen, Stephanie Robertson, Johan Hartman

Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis

Rowan T. Chlebowski, Aaron K. Aragaki, Kathy Pan, Joanne E. Mortimer, Karen C. Johnson, Jean Wactawski-Wende, Meryl S. LeBoff, Sayeh Lavasani, Dorothy Lane, Rebecca A. Nelson, JoAnn E. Manson

Racial disparities in outcomes of patients with stage I-III triple-negative breast cancer after adjuvant chemotherapy: a post-hoc analysis of the E5103 randomized trial

Saskia Leonard, Alyssa N. Jones, Lisa Newman, Mariana Chavez-MacGregor, Rachel A. Freedman, Erica L. Mayer, Elizabeth A. Mittendorf, Tari A. King, Olga Kantor

Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients

Juliet Richman, Gene Schuster, Richard Buus, Elena Lopez-Knowles, Mitch Dowsett

Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium

Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis, Peter Vuylsteke, Richard D. Gelber, Nancy Van Damme, Lien van Walle, Arlindo R. Ferreira, Matteo Lambertini, Francesca Poggio, Didier Verhoeven, Annelore Barbeaux, Francois P. Duhoux, Hans Wildiers, Carmela Caballero, Ahmad Awada, Martine Piccart-Gebhart, Kevin Punie, Evandro de Azambuja

Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study

R Charles Coombes, Christina Angelou, Zamzam Al-Khalili, William Hart, Darius Francescatti, Nicholas Wright, Ian Ellis, Andrew Green, Emad Rakha, Sami Shousha, Hemmel Amrania, Chris C. Phillips, Carlo Palmieri

Retraction Note: Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin

  • Retraction Note

Steven M. Hill, Chi Cheng, Lin Yuan, Lulu Mao, Ralf Jockers, Bob Dauchy, Tripp Frasch, David E. Blask

Retraction Note: A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells

Yanyuan Wu, Trinh Tran, Sami Dwabe, Marianna Sarkissyan, Juri Kim, Miguel Nava, Sheilah Clayton, Richard Pietras, Robin Farias-Eisner, Jaydutt V. Vadgama

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now
Video